JP2023542548A5 - - Google Patents
Info
- Publication number
- JP2023542548A5 JP2023542548A5 JP2023518938A JP2023518938A JP2023542548A5 JP 2023542548 A5 JP2023542548 A5 JP 2023542548A5 JP 2023518938 A JP2023518938 A JP 2023518938A JP 2023518938 A JP2023518938 A JP 2023518938A JP 2023542548 A5 JP2023542548 A5 JP 2023542548A5
- Authority
- JP
- Japan
- Prior art keywords
- nhr
- alkyl
- nhc
- nhr2
- cho
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ768245 | 2020-09-24 | ||
| NZ76824520 | 2020-09-24 | ||
| PCT/IB2021/058707 WO2022064430A1 (en) | 2020-09-24 | 2021-09-24 | Novel aminopyridines and their use in treating cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023542548A JP2023542548A (ja) | 2023-10-10 |
| JP2023542548A5 true JP2023542548A5 (https=) | 2025-08-14 |
| JP7839786B2 JP7839786B2 (ja) | 2026-04-02 |
Family
ID=80844550
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023518938A Active JP7839786B2 (ja) | 2020-09-24 | 2021-09-24 | 新規アミノピリジン及びその癌治療への使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230365559A1 (https=) |
| EP (1) | EP4217357A4 (https=) |
| JP (1) | JP7839786B2 (https=) |
| CN (1) | CN116669725A (https=) |
| AU (1) | AU2021346954A1 (https=) |
| CA (1) | CA3192868A1 (https=) |
| WO (1) | WO2022064430A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CR20230057A (es) | 2020-07-02 | 2023-08-15 | Incyte Corp | Compuestos tríciclicos de urea como inhibidores de jak2 v617f |
| AU2023235313A1 (en) | 2022-03-17 | 2024-10-03 | Incyte Corporation | Tricyclic urea compounds as jak2 v617f inhibitors |
| JP2026509874A (ja) * | 2023-03-13 | 2026-03-25 | インサイト・コーポレイション | キナーゼ阻害剤としての二環式尿素 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011021678A1 (ja) * | 2009-08-21 | 2011-02-24 | 武田薬品工業株式会社 | 縮合複素環化合物 |
| CA2902858A1 (en) * | 2013-02-28 | 2014-09-04 | Signal Pharmaceuticals, Llc | Treatment of cancer with tor kinase inhibitors |
| ME03336B (me) * | 2013-03-12 | 2019-10-20 | Vertex Pharma | Inhibitori dnk-pk |
| JP6883653B2 (ja) | 2016-12-20 | 2021-06-09 | アストラゼネカ・アクチエボラーグＡｓｔｒａｚｅｎｅｃａ Ａｋｔｉｅｂｏｌａｇ | アミノ−トリアゾロピリジン化合物および癌の治療におけるその使用 |
| JP7202315B2 (ja) * | 2017-05-26 | 2023-01-11 | キャンサー・リサーチ・テクノロジー・リミテッド | ベンズイミダゾロン由来のｂｃｌ６阻害剤 |
| TWI820146B (zh) * | 2018-06-15 | 2023-11-01 | 瑞典商阿斯特捷利康公司 | 嘌呤酮化合物及其在治療癌症中之用途 |
| GB201819126D0 (en) * | 2018-11-23 | 2019-01-09 | Cancer Research Tech Ltd | Inhibitor compounds |
| WO2020140054A1 (en) * | 2018-12-28 | 2020-07-02 | Spv Therapeutics Inc. | Cyclin-dependent kinase inhibitors |
-
2021
- 2021-09-24 AU AU2021346954A patent/AU2021346954A1/en active Pending
- 2021-09-24 CA CA3192868A patent/CA3192868A1/en active Pending
- 2021-09-24 JP JP2023518938A patent/JP7839786B2/ja active Active
- 2021-09-24 WO PCT/IB2021/058707 patent/WO2022064430A1/en not_active Ceased
- 2021-09-24 EP EP21871799.9A patent/EP4217357A4/en active Pending
- 2021-09-24 US US18/246,100 patent/US20230365559A1/en active Pending
- 2021-09-24 CN CN202180070775.4A patent/CN116669725A/zh active Pending